Citadel Advisors - ODONATE THERAPEUTICS INC ownership

ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 58 filers reported holding ODONATE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ODONATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$44,000
-84.3%
32,797
-65.9%
0.00%
Q3 2021$280,000
-70.2%
96,265
-64.3%
0.00%
Q2 2021$941,000
-30.3%
269,489
-31.8%
0.00%
Q1 2021$1,351,000
-64.4%
394,964
+99.9%
0.00%
Q4 2020$3,795,000
+2.4%
197,613
-28.3%
0.00%
Q3 2020$3,705,000
+69.3%
275,795
+433.4%
0.00%
-100.0%
Q2 2020$2,189,000
+67.1%
51,705
+9.0%
0.00%0.0%
Q1 2020$1,310,000
+39.4%
47,435
+63.8%
0.00%
Q4 2019$940,000
+211.3%
28,958
+149.2%
0.00%
Q3 2019$302,000
-36.7%
11,621
-65.7%
0.00%
Q4 2018$477,00033,8850.00%
Other shareholders
ODONATE THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Boxer Capital, LLC 4,207,086$5,553,0000.28%
Samsara BioCapital, LLC 700,421$925,0000.23%
Hennion & Walsh Asset Management, Inc. 69,264$91,0000.01%
ACADIAN ASSET MANAGEMENT LLC 384,995$506,0000.00%
Tower Research Capital LLC (TRC) 43,752$58,0000.00%
BESSEMER GROUP INC 230$00.00%
Newbridge Financial Services Group, Inc. 47$00.00%
SIMPLEX TRADING, LLC 2,000$2,0000.00%
View complete list of ODONATE THERAPEUTICS INC shareholders